Bio-Techne Corp
(STU:TE1)
€
69.5
0 (0%)
Market Cap: 11.07 Bil
Enterprise Value: 11.27 Bil
PE Ratio: 80.74
PB Ratio: 5.63
GF Score: 95/100 
Bio-Techne Corp at Evercore ISI HealthCONx Conference (Virtual) Transcript
Nov 29, 2022 / 01:50PM GMT
Release Date Price:
€79
(-0.63%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Okay. Thanks, everyone, for joining us this morning. We're kicking off the Life Sciences -- on the Life Sciences side, but biotech, a pleasure to have with us the management team. We have the CEO, Chuck Kummeth, we have CFO, Jim Hippel, with us. We also have the President of our Protein Sciences Will Geist and from Investor Relations, David Clair. So with that, Chuck and Jim, thanks for taking the time for being with us this morning.
Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director
Sure.
Questions & Answers
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
So I wanted to start with -- this -- the last quarter, this was unusual for biotech. You guys are known as one of the high
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers